Pharmarama, a leader in the strategic sourcing of comparator drugs for
global clinical trials, today announced that the Massachusetts
Department of Public Health has granted the company a Wholesale
Distributor’s License (WDL). The license enables Pharmarama to operate
its pharmaceutical cold-chain and ambient storage and distribution
facility in suburban Boston to provide extensive sourcing and comparator
product storage services for its clients.
“This new facility will enable us to introduce our proprietary
GlobalBatch™ program, to serve clients in a new paradigm”
“Pharmarama is a one-stop shop for pharmaceutical companies in the
United States and throughout the European Union (EU),” said company
President Rosemary Bensley. “From our newly licensed facility in
Medfield, Mass., we will now serve as a hub for our U.S.-based
pharmaceutical clients to efficiently procure U.S. products for their
clinical trials. Receipt of this WDL reflects not only our compliance
with Good Distribution Practice, but also our commitment to quality
underpinned by a robust Quality Management System.
“This new facility will enable us to introduce our proprietary
GlobalBatch™ program, to serve clients in a new paradigm,” continued
Bensley. “Pharmarama has unique knowledge of the regulatory and data
requirements for use of an EU-sourced drug in global adjunctive and
comparator studies. In addition, we have the supplier relationships and
the infrastructure necessary to procure comparators – often through a
single source – for trials conducted anywhere in the world. This skill
set enables us to assist clients in developing a highly effective
sourcing strategy.”